Encapsulation of pancreatic cells derived from human pluripotent stem cells
US9132226B2 · kind B2 · utility
18Cited by
94References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 24, 2013 |
| Grant date | Sep 15, 2015 |
| Priority date | — |
| Expiry date | May 24, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2506/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods for encapsulating pancreatic progenitors in a biocompatible semi-permeable encapsulating device. The present invention also relates to production of human insulin in a mammal in response to glucose stimulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.